Ali Rezvan
Impact in
-
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
-
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
-
- SARS-CoV-2 and COVID-19 Research 3
-
- CRISPR and Genetic Engineering 2
- Single-cell and spatial transcriptomics 1
- Co-authors
- Navin Varadarajan (8 shared papers)Mohsen Fathi (4 shared papers)Xingyue An (4 shared papers)Melisa Martinez-Paniagua (4 shared papers)Xinli Liu (3 shared papers)Shailbala Singh (2 shared papers)Sujit Biswas (2 shared papers)Cassian Yee (2 shared papers)
- Journals
- iScience (2 papers)Journal of Clinical Medicine (1 paper)Cell Death and Disease (1 paper)Nature Communications (1 paper)The Canadian Journal of Chemical Engineering (1 paper)
- Partner nations
- United StatesSwitzerlandIran
In The Last Decade
Ali Rezvan
9 papers receiving 153 citations
Peers
Comparison fields: 5 of 47
- Infectious Diseases 52
- Immunology 49
- Microbiology 11
- Biophysics 10
- Oncology 46
Countries citing papers authored by Ali Rezvan
This map shows the geographic impact of Ali Rezvan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ali Rezvan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ali Rezvan more than expected).
Fields of papers citing papers by Ali Rezvan
This network shows the impact of papers produced by Ali Rezvan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ali Rezvan. The network helps show where Ali Rezvan may publish in the future.
Co-authors
The 25 scholars most cited alongside Ali Rezvan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 66 | |
| 2 | 2022 | 36 | |
| 3 | 2024 | 16 | |
| 4 | 2019 | 12 | |
| 5 | 2019 | 9 | |
| 6 | 2023 | 7 | |
| 7 | 2024 | 7 | |
| 8 | 2022 | 2 | |
| 9 | 2020 | 2 |
About Ali Rezvan
Ali Rezvan is a scholar working on Infectious Diseases, Molecular Biology, Oncology, Immunology and Biomedical Engineering, having authored 9 papers that have together received 157 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (3 papers), CAR-T cell therapy research (3 papers), Immunotherapy and Immune Responses (2 papers), CRISPR and Genetic Engineering (2 papers), Single-cell and spatial transcriptomics (1 paper), MicroRNA in disease regulation (1 paper), Cell Image Analysis Techniques (1 paper) and interferon and immune responses (1 paper). The work is most often cited by research in Infectious Diseases (52 citations), Immunology (49 citations), Microbiology (11 citations), Biophysics (10 citations) and Oncology (46 citations). Ali Rezvan has collaborated with scholars based in United States, Switzerland and Iran. Frequent co-authors include Navin Varadarajan, Mohsen Fathi, Xingyue An, Melisa Martinez-Paniagua, Xinli Liu, Shailbala Singh, Sujit Biswas, Cassian Yee, Irfan Bandey and Mario L. Marques‐Piubelli. Their work appears in journals such as iScience, Journal of Clinical Medicine, Cell Death and Disease, Nature Communications and The Canadian Journal of Chemical Engineering.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.